SLC5A2 and diabetes mellitus: So, Gallo et al. suggested that adequate, and stable blood glucose lowering, perhaps with multiple medications, including higher- and/or multiple daily-dosing of SGLT2 inhibition in combination with a RAS blockade, can be necessary to accomplished maximal nephroprotection in diabetes [83].